9.870USD-0.10%Mkt Cap: 512.57M USDP/E: —Last update: 2026-06-01
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap512.57M USD
Enterprise Value147.70M USD
Revenue (TTM)88.24M USD
Gross Profit-128.53M USD
Net Income (TTM)-140.11M USD
Revenue/Share1.446 USD
Last Price9.870 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees196
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.66
PEG—
EV/EBITDA-0.86
EV/Revenue1.67
P/S5.87
P/B1.15
EPS (TTM)-2.57
EPS (Forward)-3.72
52W Range
3.48072% of range12.34
52W High12.34 USD
52W Low3.480 USD
Profitability
Gross Margin-145.66%
Oper. Margin-2416.15%
EBITDA Margin-194.28%
Profit Margin-164.43%
ROE-27.71%
ROA-24.72%
Growth
Revenue Growth21664.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-109.08M USD
CapEx (TTM)536.00K USD
FCF Margin-78.60%
FCF Yield-13.53%
Net Debt-370.36M USD
Net Debt/EBITDA2.16
Balance Sheet
Debt/Equity0.04
Current Ratio9.34
Quick Ratio9.01
Book Value/Sh8.644 USD
Cash/Share7.477 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)28.22 USD
Target Range17.00 USD – 36.00 USD
# Analysts9
Ownership
Shares Out.52.28M
Float38.84M
Insiders3.55%
Institutions98.35%
Short Interest
Short Ratio18.4d
Short % Float26.72%
Short % Out.23.11%
Shares Short12.08M
Short (prev mo.)11.52M
Technical
SMA 509.493 (+4.0%)
SMA 2009.046 (+9.1%)
Beta2.76
S&P 52W Chg27.94%
Avg Vol (30d)684.05K
Avg Vol (10d)556.86K
Technical Indicators
RSI (14)56.7
MACD-0.1576
MACD Signal-0.1647
MACD Hist.+0.0071
BB Upper10.97 USD
BB Middle9.410 USD
BB Lower7.854 USD
BB Width33.08%
ATR (14)0.6078 USD
Vol Ratio (20d)5.03x